Year in Review in EGFR-Mutated NSCLC: Impact of Recent Advances Across the Disease Continuum

Content Format:

Video

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

1.00
Year in Review in EGFR-Mutated NSCLC: First-line Therapy Selection for EGFRm NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Year in Review in EGFR-Mutated NSCLC: Treatment Strategies for 2L+ and Exon 20 Insertions

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Analysis: Clinical Advances Journal Club on Emerging TROP-2 and TIGIT Therapies in Lung Cancer

Content Format:

Text Module

Credit Type:

AMA | EBAC®

Credits:

1.00
Emerging TROP-2 and TIGIT Therapies in Lung Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Exploring TROP2 and TIGIT Therapies in Lung Cancer: Lessons From Recent Trials and Looking Forward to New Horizons

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
TROP2 and TIGIT Therapies for Advanced NSCLC: Where Are We Today?

Content Format:

Podcast

Credit Type:

--

Credits:

--
Expanding Therapeutic Horizons: Targeting Non-V600 BRAF Mutations in Solid Tumors

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
EGFR Exon 20–Altered NSCLC: A Personalized Approach to Improve Patient Outcomes

Content Format:

Video

Credit Type:

AMA

Credits:

0.50
ExpressPointsEGFR Exon 20–Altered NSCLC: A Personalized Approach to Improve Patient Outcomes

Content Format:

Slideset

Credit Type:

--

Credits:

--
Assessing EGFR Mutation and MET Amplifications Status in NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--